Article Versions Notes

Le X, Molife C, Leusch MS, Rizzo MT, Peterson PM, Caria N, Chen Y, Gugel EG, Visseren-Grul C. TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer. Cancers. 2022; 14(24):6127. https://doi.org/10.3390/cancers14246127

Le, Xiuning, Cliff Molife, Mark S. Leusch, Maria Teresa Rizzo, Patrick M. Peterson, Nicola Caria, Yongmei Chen, Elena Gonzalez Gugel, and Carla Visseren-Grul. 2022. "TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer" Cancers 14, no. 24: 6127. https://doi.org/10.3390/cancers14246127

Le, X., Molife, C., Leusch, M. S., Rizzo, M. T., Peterson, P. M., Caria, N., Chen, Y., Gugel, E. G., & Visseren-Grul, C. (2022). TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer. Cancers, 14(24), 6127. https://doi.org/10.3390/cancers14246127